Global In Vivo Bioreactor Market

1. Executive Summary

2. Introduction
     2.1. Study Objectives
     2.2. Market Definition
          2.2.1. Market Covered
          2.2.2. Geographical Coverage
          2.2.3. Study Years & Currency
     2.3. Market Stakeholders
     2.4. Key Questions this Study will Answer
     2.5. GMI Research’s Approach & Methodology

3. Global In Vivo Bioreactor Market - Overview
     3.1. Introduction
     3.2. Market Segmentation
     3.3. Value Chain Analysis
     3.4. Drivers
     3.5. Restraints
     3.6. Trends

4. Global In Vivo Bioreactor as a Service Market Revenue Forecast till 2025

5. Global In Vivo Bioreactor as a Service Market by End User Revenue Forecast till 2025
     5.1. Research &Development Departments
     5.2. Biopharmaceutical Manufacturers
     5.3. Contract Research Organizations
     5.4. Others

6. Global In Vivo Bioreactor as a Service Market by Material Type Revenue Forecast till 2025
     6.1. Single-Use
     6.2. Glass
     6.3. Stainless Steel

7. Global In Vivo Bioreactor as a Service Market by Usage Revenue Forecast till 2025
     7.1. Pilot-scale production
     7.2. Lab-scale production
     7.3. Full-scale production

8. Global In Vivo Bioreactor as a Service Market by Capacity Revenue Forecast till 2025
     8.1. < 1L – Benchtop Unit
     8.2. 5L-20L
     8.3. 20L-200L
     8.4. 200L-1500L
     8.5. Above 1500L – Large-scale unit

9. Global In Vivo Bioreactor as a Service Market by Geography Revenue Forecast till 2025
     9.1. Europe In Vivo Bioreactor as a Service Market Revenue Forecast till 2025 (Option 1: 25% customization)
          9.1.1. Europe In Vivo Bioreactor as a Service Market by End User
                    9.1.1.1. Research &Development Departments
                    9.1.1.2. Biopharmaceutical Manufacturers
                    9.1.1.3. Contract Research Organizations
                    9.1.1.4. Others

          9.1.2. Europe In Vivo Bioreactor as a Service Market by Material Type
                    9.1.2.1. Single-Use
                    9.1.2.2. Glass
                    9.1.2.3. Stainless Steel

          9.1.3. Europe In Vivo Bioreactor as a Service Market by Usage
                    9.1.3.1. Pilot-scale production
                    9.1.3.2. Lab-scale production
                    9.1.3.3. Full-scale production

          9.1.4. Europe In Vivo Bioreactor as a Service Market by Capacity
                    9.1.4.1. < 1L – Benchtop Unit
                    9.1.4.2. 5L-20L
                    9.1.4.3. 20L-200L
                    9.1.4.4. 200L-1500L
                    9.1.4.5. Above 1500L – Large-scale unit

     9.2. North America In Vivo Bioreactor as a Service Market Revenue Forecast till 2025(Option 2: 25% customization)
          9.2.1. North America In Vivo Bioreactor as a Service Market by End User
                    9.2.1.1. Research &Development Departments
                    9.2.1.2. Biopharmaceutical Manufacturers
                    9.2.1.3. Contract Research Organizations
                    9.2.1.4. Others
          9.2.2. North America In Vivo Bioreactor as a Service Market by Material Type
                    9.2.2.1. Single-Use
                    9.2.2.2. Glass
                    9.2.2.3. Stainless Steel
          9.2.3. North America In Vivo Bioreactor as a Service Market by Usage
                    9.2.3.1. Pilot-scale production
                    9.2.3.2. Lab-scale production
                    9.2.3.3. Full-scale production
          9.2.4. North America In Vivo Bioreactor as a Service Market by Capacity
                    9.2.4.1. < 1L – Benchtop Unit
                    9.2.4.2. 5L-20L
                    9.2.4.3. 20L-200L
                    9.2.4.4. 200L-1500L
                    9.2.4.5. Above 1500L – Large-scale unit

     9.3. Asia-Pacific In Vivo Bioreactor as a Service Market Revenue Forecast till 2025 (Option 3: 25% customization)
          9.3.1. Asia-Pacific In Vivo Bioreactor as a Service Market by End User
                    9.3.1.1. Research &Development Departments
                    9.3.1.2. Biopharmaceutical Manufacturers
                    9.3.1.3. Contract Research Organizations
                    9.3.1.4. Others

          9.3.2. Asia-Pacific In Vivo Bioreactor as a Service Market by Material Type
                    9.3.2.1. Single-Use
                    9.3.2.2. Glass
                    9.3.2.3. Stainless Steel

          9.3.3. Asia-Pacific In Vivo Bioreactor as a Service Market by Usage
                    9.3.3.1. Pilot-scale production
                    9.3.3.2. Lab-scale production
                    9.3.3.3. Full-scale production

          9.3.4. Asia-Pacific In Vivo Bioreactor as a Service Market by Capacity
                    9.3.4.1. < 1L – Benchtop Unit
                    9.3.4.2. 5L-20L
                    9.3.4.3. 20L-200L
                    9.3.4.4. 200L-1500L
                    9.3.4.5. Above 1500L – Large-scale unit

     9.4. Rest of the world In Vivo Bioreactor as a Service Market Revenue Forecast till 2025
          9.4.1. Middle East & Africa In Vivo Bioreactor as a Service Market by End User
                    9.4.1.1. Research &Development Departments
                    9.4.1.2. Biopharmaceutical Manufacturers
                    9.4.1.3. Contract Research Organizations
                    9.4.1.4. Others

          9.4.2. Middle East & Africa In Vivo Bioreactor as a Service Market by Material Type
                    9.4.2.1. Single-Use
                    9.4.2.2. Glass
                    9.4.2.3. Stainless Steel

          9.4.3. Middle East & Africa In Vivo Bioreactor as a Service Market by Usage
                    9.4.3.1. Pilot-scale production
                    9.4.3.2. Lab-scale production
                    9.4.3.3. Full-scale production

          9.4.4. Middle East & Africa In Vivo Bioreactor as a Service Market by Capacity
                    9.4.4.1. < 1L – Benchtop Unit
                    9.4.4.2. 5L-20L
                    9.4.4.3. 20L-200L
                    9.4.4.4. 200L-1500L
                    9.4.4.5. Above 1500L – Large-scale unit

10. Competitive Landscape
       10.1. Porter 5 Analysis
       10.2. Major players and their key strategies
       10.3. Company Share Analysis

11. Company Profiles (Option 5: 25% Customization - Profiles of 5 Additional Companies of your Choice)
       11.1. Pall Corporation (Danaher Corporation)
             11.1.1. Company Overview
             11.1.2. Financials
             11.1.3. Recent Developments

       11.2. Eppendorf AG
             11.2.1. Company Overview
             11.2.2. Financials
             11.2.3. Recent Developments

       11.3. Merck Millipore Corporation
             11.3.1. Company Overview
             11.3.2. Financials
             11.3.3. Recent Developments

       11.4. Sartorius AG
             11.4.1. Company Overview
             11.4.2. Financials
             11.4.3. Recent Developments

       11.5. GE Healthcare
             11.5.1. Company Overview
             11.5.2. Financials
             11.5.3. Recent Developments

       11.6. Thermo Fisher Scientific Inc.
             11.6.1. Company Overview
             11.6.2. Financials
             11.6.3. Recent Developments

       11.7. ZETA Holdings GmbH
             11.7.1. Company Overview
             11.7.2. Financials
             11.7.3. Recent Developments

       11.8. Bioengineering AG
             11.8.1. Company Overview
             11.8.2. Financials
             11.8.3. Recent Developments

       11.9. Applikon Biotechnology Inc.
             11.9.1. Company Overview
             11.9.2. Financials
             11.9.3. Recent Developments

       11.10. Solaris Biotech
             11.10.1. Company Overview
             11.10.2. Financials
             11.10.3. Recent Developments

       11.11. ALA Scientific Instruments, Inc.
             11.11.1. Company Overview
             11.11.2. Financials
             11.11.3. Recent Developments

       11.12. Getinge AB
             11.12.1. Company Overview
             11.12.2. Financials
             11.12.3. Recent Developments

       11.13. Harvard Bioscience, Inc.
             11.13.1. Company Overview
             11.13.2. Financials
             11.13.3. Recent Developments

       11.14. Lifeline Scientific, Inc. (Organ Recovery Systems, Inc.)
             11.14.1. Company Overview
             11.14.2. Financials
             11.14.3. Recent Developments

       11.15. Livanova PLC
             11.15.1. Company Overview
             11.15.2. Financials
             11.15.3. Recent Developments

       11.16. Medtronic PLC
             11.16.1. Company Overview
             11.16.2. Financials
             11.16.3. Recent Developments

       11.17. Nipro Corporation
             11.17.1. Company Overview
             11.17.2. Financials
             11.17.3. Recent Developments

       11.18. Repligen Corporation
             11.18.1. Company Overview
             11.18.2. Financials
             11.18.3. Recent Developments

       11.19. Terumo Corporation
             11.19.1. Company Overview
             11.19.2. Financials
             11.19.3. Recent Developments

       11.20. Spectrum Laboratories, Inc.
             11.20.1. Company Overview
             11.20.2. Financials
             11.20.3. Recent Developments

12. About GMI Research